Quantitative MR Biomarkers for Sarcoma Treatment
The purpose of this study is to determine if MRI imaging can be used to accurately determine
if a sarcoma is responding to the type of chemotherapy being used or if it is ineffective
early on in the treatment; instead of finding this out 2-3 months later. If it is
determined that MRI can accurately diagnose tumor response, medications can be switched
early on potentially improv8ing the patients'chances of recovery.
Allocation: Non-Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label
To determine if MRI imaging can accurately determine if a sarcoma (tumor)is responding to the type of chemotherapy being used.
To image and evaluate the size of the soft tissue tumor prior to chemotherapy treatment.
Baseline prior to chemo
Gary Luker, M.D.
Universityof Michigan Health Systems
United States: Institutional Review Board
|University of Michigan Health System||Ann Arbor, Michigan|